Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2114796 | Cancer Letters | 2008 | 6 Pages |
Abstract
The goal was to evaluate whether melatonin (Mel) down-regulates hTERT expression induced by 17β-estradiol (E2) or cadmium (Cd) in breast cancer cells. We found that: (a) Mel inhibits E2 or Cd-induced hTERT transcription in hTERT-Luc transfected MCF-7 cells, (b) Mel significantly reduces E2- and Cd-mediated hTERT transactivation triggered by ERα in transfected HeLa cells, (c) Mel inhibits hTERT expression induced by E2 or Cd in MCF-7 cells. Melatonin inhibition of telomerase activity supports a possible role in treatment of estrogen-dependent tumors or carcinogenesis by environmental or occupational exposure to xenoestrogens.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Carlos M. Martínez-Campa, Carolina Alonso-González, Maria D. Mediavilla, Samuel Cos, Alicia González, Emilio J. Sanchez-Barcelo,